Medexus Pharmaceuticals - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsMedexus Pharmaceuticals

Medexus Pharmaceuticals

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Ixinity	Coagulation factor ix recombinant human	2015-04-29		—
Rasuvo	Methotrexate	2014-07-10	2026-2033	Leukemia , Juvenile arthritis , Psoriatic arthritis , Breast neoplasms , Psoriasis , Stomach neoplasms , Esophageal neoplasms , Rheumatoid arthritis , Lung neoplasms , Crohn disease , Precursor cell lymphoblastic leukemia-lymphoma , Hydatidiform mole , Osteosarcoma , Arthritis , Mycosis fungoides , Testicular neoplasms , Choriocarcinoma

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

hematopoietic stem cell transplantation

,

,

,

precursor cell lymphoblastic leukemia-lymphoma

,

hemoglobinopathies

,

bone marrow failure disorders

,

inborn errors metabolism

,

primary immunodeficiency diseases

,

hematologic neoplasms

,

,

b-cell chronic lymphocytic leukemia

,

biphenotypic leukemia acute

,

bcr-abl positive chronic myelogenous leukemia

,

myelomonocytic leukemia chronic

,

hodgkin disease

,

b-cell lymphoma marginal zone

,

prolymphocytic leukemia

,

follicular lymphoma

,

mantle-cell lymphoma

,

waldenstrom macroglobulinemia

,

large b-cell lymphoma diffuse

,

large-cell lymphoma anaplastic

,

burkitt lymphoma

,

graft vs host disease

,

myelomonocytic leukemia juvenile

,

myeloid leukemia

,

,

multiple myeloma

,

metabolic diseases

,

sickle cell anemia

,

,

,

wiskott-aldrich syndrome

,

hemophagocytic lymphohistiocytosis

,

diamond-blackfan anemia

,

shwachman-diamond syndrome

,

dyskeratosis congenita

,

refractory anemia with excess of blasts

,

myelodysplastic syndromes

,

myeloid leukemia acute

,

Coagulation factor ix recombinant human

healthy volunteers/patients

,

,

factor vii deficiency

,

,

thromboembolism

,

blood transfusion

,

postoperative complications

,

congenital heart defects

,

acute lung injury

,

,

transfusion-related acute lung injury

,

transfusion reaction

,

venous thromboembolism

,

,

embolism and thrombosis

,

,

,

,

hematologic diseases

,

wounds and injuries

,

hemorrhagic disorders

,

coagulation protein disorders

,

inborn genetic diseases

,

thrombocytopenia

,

hemorrhagic shock

,

x-linked genetic diseases

,

inherited blood coagulation disorders

,

,

traumatic brain injuries

,

,

,

,

blood coagulation disorders

,

hemostatic disorders

,

,

intracranial hemorrhages

,

cardiac surgical procedures

,

surgical blood loss

,

,

cardiopulmonary bypass

,

,

cardiovascular surgical procedures

,

,

,

cerebral hemorrhage

,

,

cardiac arrhythmias

,

platelet transfusion

,

liver cirrhosis

,

,

knee osteoarthritis

,

prostatic neoplasms

,

hip osteoarthritis

,

spinal dysraphism

,

heart valve diseases

,

,

hypersensitivity

,

von willebrand diseases

,

mucopolysaccharidoses

,

mucopolysaccharidosis i

,

mucopolysaccharidosis ii

,

,

,

connective tissue diseases

,

sickle cell anemia

,

blood platelet disorders

,

,

liver transplantation

,

,

perioperative care

,

genetic therapy

,

,

type 3 von willebrand disease

Trenonacog alfa

,

diabetes mellitus

,

diabetic neuropathies

,

breast neoplasms

,

circulating neoplastic cells

,

neoplasm metastasis

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use